Copy
See below for a daily digest of the latest Huntington's Disease news!

Huntington’s Treatment Candidate Gets FDA Orphan Drug Designation

Aug 26, 2016 07:00 am | Özge Özkaya, PhD

 

Huntington'sVaccinex Inc. a clinical-stage biotechnology company recently announced that their drug candidate, VX15 developed for the treatment of Huntington’s disease (HD) received orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA).

The post Huntington’s Treatment Candidate Gets FDA Orphan Drug Designation appeared first on Huntington's Disease News.

Read More
share on Twitter Like Huntington’s Treatment Candidate Gets FDA Orphan Drug Designation on Facebook

Researchers Shed Light on Cognitive Problems in Huntington’s Disease, Potentially Leading to Future Therapies

Aug 24, 2016 07:00 am | Alisa Woods, PhD

 

cognitive difficulties in Huntington's diseaseA new study from researchers in Spain may increase understanding of a less recognized aspect of Huntington’s disease (HD): cognitive problems. The article examines the possible causes of cognitive difficulties in HD and how they might be addressed through new therapies. The report, “Cognitive Dysfunction in Huntington’s Disease: Mechanisms and Therapeutic Strategies Beyond BDNF,” appeared in the journal Brain […]

The post Researchers Shed Light on Cognitive Problems in Huntington’s Disease, Potentially Leading to Future Therapies appeared first on Huntington's Disease News.

Read More
share on Twitter Like Researchers Shed Light on Cognitive Problems in Huntington’s Disease, Potentially Leading to Future Therapies on Facebook

Recent Posts

Promising Target for Huntington’s Disease Found
Neurodegeneration in Huntington’s Linked to Protein Complex Crucial for Developing Brain
Enzymes Linked to Huntington’s Seen for 1st Time in Living Brain
Promising Huntington’s Therapy Candidate Discussed at Hereditary Disease Foundation Meeting
Prana’s PBT2 Shown to Lower Tau Protein in Neurodegeneration Cell Model

Copyright © 2016 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences